ClinicalTrials.gov
public full text
Public Domain
Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study
The main aims of this study are to determine whether: a) psoriasis patients with or without arthritis have more cardiovascular inflammation than healthy subjects and b)3 months of etanercept (enbrel) therapy (prescribed to psoriasis patients with or without arthritis by their treating clinicians) will decrease cardiovascular inflammation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis#800198
- Study of Etanercept in the Treatment of Psoriasis in Adult Subjects#1102760
- Development of a predictive marker panel for the individualised bDMARD therapy of psoriatic arthritis: protocol for a prospective observational study (Integrate-PsA).#375351
- Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients#889243
- Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis#903453
Record · ID 805623
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive